DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 151 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $142,210 | -26.6% | 11,180 | -18.8% | 0.00% | -50.0% |
Q2 2023 | $193,868 | -17.0% | 13,769 | -9.0% | 0.00% | 0.0% |
Q1 2023 | $233,712 | +26.0% | 15,127 | +33.7% | 0.00% | 0.0% |
Q4 2022 | $185,420 | -7.3% | 11,313 | +4.8% | 0.00% | 0.0% |
Q3 2022 | $200,000 | +94.2% | 10,797 | -2.4% | 0.00% | +100.0% |
Q1 2022 | $103,000 | -3.7% | 11,066 | +1.2% | 0.00% | 0.0% |
Q4 2021 | $107,000 | -71.5% | 10,935 | -1.1% | 0.00% | -66.7% |
Q3 2021 | $376,000 | -6.2% | 11,052 | +0.8% | 0.00% | 0.0% |
Q2 2021 | $401,000 | -17.0% | 10,965 | +1.8% | 0.00% | -25.0% |
Q1 2021 | $483,000 | -20.4% | 10,773 | +1.4% | 0.00% | -33.3% |
Q4 2020 | $607,000 | +8.0% | 10,628 | -3.0% | 0.01% | 0.0% |
Q3 2020 | $562,000 | +18.3% | 10,956 | +37.7% | 0.01% | -14.3% |
Q2 2020 | $475,000 | +92.3% | 7,955 | +32.8% | 0.01% | +75.0% |
Q1 2020 | $247,000 | – | 5,992 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 2,086,723 | $85,910,000 | 25.70% |
SV Health Investors, LLC | 449,951 | $18,525,000 | 15.54% |
Redmile Group, LLC | 5,116,263 | $210,637,000 | 5.90% |
Eversept Partners, LP | 414,081 | $17,047,715 | 4.24% |
Sunesis Advisors, LLC | 96,299 | $3,965,000 | 3.99% |
Avoro Capital Advisors LLC | 2,000,000 | $82,340,000 | 2.78% |
Opaleye Management Inc. | 222,000 | $9,140,000 | 2.42% |
SECTORAL ASSET MANAGEMENT INC | 204,059 | $8,401,000 | 1.61% |
Artal Group S.A. | 800,000 | $32,936,000 | 1.39% |
Atika Capital Management LLC | 141,000 | $5,805,000 | 1.11% |